Name | Number of supported studies | Average coverage | |
---|---|---|---|
group 3 innate lymphoid cell | 4 studies | 44% ± 18% |
Insufficient scRNA-seq data for expression of RORC at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 2594.33 | 89 / 89 | 95% | 26.84 | 857 / 901 |
thymus | 99% | 3744.89 | 648 / 653 | 96% | 35.91 | 580 / 605 |
liver | 100% | 7161.52 | 226 / 226 | 94% | 51.53 | 381 / 406 |
prostate | 89% | 2932.14 | 219 / 245 | 99% | 40.88 | 495 / 502 |
pancreas | 100% | 4091.75 | 327 / 328 | 82% | 12.03 | 146 / 178 |
breast | 60% | 1078.01 | 277 / 459 | 87% | 22.39 | 970 / 1118 |
stomach | 74% | 1888.35 | 266 / 359 | 58% | 7.17 | 167 / 286 |
lung | 69% | 757.26 | 399 / 578 | 56% | 15.18 | 651 / 1155 |
intestine | 44% | 735.04 | 425 / 966 | 65% | 9.08 | 342 / 527 |
muscle | 100% | 10463.28 | 803 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 31% | 255.27 | 79 / 258 | 68% | 21.71 | 156 / 230 |
skin | 72% | 2469.87 | 1302 / 1809 | 10% | 1.50 | 47 / 472 |
bladder | 38% | 420.38 | 8 / 21 | 39% | 5.91 | 199 / 504 |
ovary | 2% | 12.28 | 4 / 180 | 67% | 9.13 | 286 / 430 |
heart | 59% | 658.63 | 510 / 861 | 0% | 0 | 0 / 0 |
esophagus | 28% | 264.30 | 400 / 1445 | 27% | 3.90 | 50 / 183 |
uterus | 7% | 118.54 | 12 / 170 | 41% | 6.10 | 189 / 459 |
adipose | 23% | 226.80 | 273 / 1204 | 0% | 0 | 0 / 0 |
brain | 18% | 209.21 | 463 / 2642 | 0% | 0.01 | 1 / 705 |
eye | 0% | 0 | 0 / 0 | 15% | 2.48 | 12 / 80 |
peripheral blood | 10% | 91.44 | 91 / 929 | 0% | 0 | 0 / 0 |
spleen | 10% | 65.81 | 23 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.76 | 4 / 45 |
blood vessel | 0% | 6.89 | 5 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0019218 | Biological process | regulation of steroid metabolic process |
GO_0072539 | Biological process | T-helper 17 cell differentiation |
GO_0036315 | Biological process | cellular response to sterol |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0030522 | Biological process | intracellular receptor signaling pathway |
GO_0010906 | Biological process | regulation of glucose metabolic process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0042753 | Biological process | positive regulation of circadian rhythm |
GO_0045598 | Biological process | regulation of fat cell differentiation |
GO_0060612 | Biological process | adipose tissue development |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0008142 | Molecular function | oxysterol binding |
GO_0005515 | Molecular function | protein binding |
GO_0098531 | Molecular function | ligand-activated transcription factor activity |
Gene name | RORC |
Protein name | RAR-related orphan receptor C (RORC protein) Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) RORC RAR related orphan receptor C |
Synonyms | NR1F3 RZRG RORG |
Description | FUNCTION: Nuclear receptor that binds DNA as a monomer to ROR response elements (RORE) containing a single core motif half-site 5'-AGGTCA-3' preceded by a short A-T-rich sequence. Key regulator of cellular differentiation, immunity, peripheral circadian rhythm as well as lipid, steroid, xenobiotics and glucose metabolism . Considered to have intrinsic transcriptional activity, have some natural ligands like oxysterols that act as agonists (25-hydroxycholesterol) or inverse agonists (7-oxygenated sterols), enhancing or repressing the transcriptional activity, respectively . Recruits distinct combinations of cofactors to target gene regulatory regions to modulate their transcriptional expression, depending on the tissue, time and promoter contexts. Regulates the circadian expression of clock genes such as CRY1, BMAL1 and NR1D1 in peripheral tissues and in a tissue-selective manner. Competes with NR1D1 for binding to their shared DNA response element on some clock genes such as BMAL1, CRY1 and NR1D1 itself, resulting in NR1D1-mediated repression or RORC-mediated activation of the expression, leading to the circadian pattern of clock genes expression. Therefore influences the period length and stability of the clock. Involved in the regulation of the rhythmic expression of genes involved in glucose and lipid metabolism, including PLIN2 and AVPR1A . Negative regulator of adipocyte differentiation through the regulation of early phase genes expression, such as MMP3. Controls adipogenesis as well as adipocyte size and modulates insulin sensitivity in obesity. In liver, has specific and redundant functions with RORA as positive or negative modulator of expression of genes encoding phase I and Phase II proteins involved in the metabolism of lipids, steroids and xenobiotics, such as SULT1E1. Also plays a role in the regulation of hepatocyte glucose metabolism through the regulation of G6PC1 and PCK1 . Regulates the rhythmic expression of PROX1 and promotes its nuclear localization . Plays an indispensable role in the induction of IFN-gamma dependent anti-mycobacterial systemic immunity . .; FUNCTION: [Isoform 2]: Essential for thymopoiesis and the development of several secondary lymphoid tissues, including lymph nodes and Peyer's patches. Required for the generation of LTi (lymphoid tissue inducer) cells. Regulates thymocyte survival through DNA-binding on ROREs of target gene promoter regions and recruitment of coactivaros via the AF-2. Also plays a key role, downstream of IL6 and TGFB and synergistically with RORA, for lineage specification of uncommitted CD4(+) T-helper (T(H)) cells into T(H)17 cells, antagonizing the T(H)1 program. Probably regulates IL17 and IL17F expression on T(H) by binding to the essential enhancer conserved non-coding sequence 2 (CNS2) in the IL17-IL17F locus. May also play a role in the pre-TCR activation cascade leading to the maturation of alpha/beta T-cells and may participate in the regulation of DNA accessibility in the TCR-J(alpha) locus. . |
Accessions | ENST00000651814.1 ENST00000697811.1 ENST00000356728.11 [P51449-2] A0A2K9REZ7 P51449 A0A494C0S6 A0A1W2PRM4 ENST00000652040.2 ENST00000638901.1 ENST00000318247.7 [P51449-1] Q6I9R9 ENST00000651893.1 A0A8V8TL94 A0A494C174 A0A494C0H2 |